TABLE 2.

Results of Huber regression analysis conducted to assess the concordance between RNA-Seq and NanoString measurements across a range of infection conditions.

Condition	$\text{Pseudo\hspace{0.17em}}{R}^2$	$\text{Robust\hspace{0.17em}}{R}^2$	Intercept	Slope	p-value
IAV-none-24	0.73	0.80	49.80	6.93	<0.0001
IAV-UV-24	0.84	0.71	32.54	7.60	<0.0001
MPV-none-24	0.86	0.73	41.58	7.20	<0.0001
MPV-UV-24	0.73	0.75	38.53	7.07	<0.0001
PIV3-none-24	0.86	0.80	36.05	8.88	<0.0001
PIV3-UV-24	0.85	0.78	38.25	8.09	<0.0001
Mock-24	0.89	0.76	46.80	7.71	<0.0001
Untreated-24	0.79	0.79	41.08	7.94	<0.0001
IAV-none-72	0.69	0.78	35.49	6.00	<0.0001
IAV-UV-72	0.80	0.80	27.03	6.12	<0.0001
MPV-none-72	0.82	0.78	28.90	6.07	<0.0001
MPV-UV-72	0.82	0.70	30.78	6.01	<0.0001
PIV3-none-72	0.76	0.75	29.70	5.81	<0.0001
PIV3-UV-72	0.80	0.74	21.37	5.52	<0.0001
Mock-72	0.79	0.73	38.69	7.50	<0.0001
Untreated-72	0.83	0.75	45.11	6.86	<0.0001